[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100349858":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":33,"centralContacts":37,"locations":46,"responsibleParty":63,"collaborators":10,"id":65,"slug":66,"hasResults":67,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":10,"eligibilityCriteria":71,"healthyVolunteers":72,"sex":73,"minAge":74,"maxAge":75,"enrollmentInfo":76,"targetDuration":10,"studyType":79,"phases":10,"briefSummary":80,"conditions":81,"keywords":85,"overallStatus":49,"whyStopped":10,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Imperial College London","OTHER",[8,16],{"label":9,"type":10,"description":11,"interventionNames":12},"Control group",null,"Fourty control participants who have not received upper gastrointestinal surgery.",[13,14,15],"Other: 3D motion capture system","Other: Incentive spirometry","Other: Questionnaires",{"label":17,"type":10,"description":18,"interventionNames":19},"Open surgery","Sixty patients who have undergone open removal of oesophagus more than one year ago.",[13,14,15],[21,25,29],{"type":6,"name":22,"description":23,"armGroupLabels":24,"otherNames":10},"3D motion capture system","Small reflective markers and inertia measurement units will be placed on the chest of the patients using hypoallergenic adhesive and a motion capture system will pick up a 3D image via these markers non-invasively.",[9,17],{"type":6,"name":26,"description":27,"armGroupLabels":28,"otherNames":10},"Incentive spirometry","Incentive spirometry is a non-invasive device for assessment of pulmonary function.",[9,17],{"type":6,"name":30,"description":31,"armGroupLabels":32,"otherNames":10},"Questionnaires","Three validated, European Organisation for Research and Treatment of Cancer Quality-of-life Questionnaire Core 30 (EORTC QLQ-C30) and Oesophago-Gastric Module 25 (EORTC QLQ-OG25) and LASORS questionnaire.",[9,17],[34],{"name":35,"affiliation":5,"role":36},"Sheraz R Markar, Dr","PRINCIPAL_INVESTIGATOR",[38,42],{"name":35,"role":39,"phone":40,"phoneExt":10,"email":41},"CONTACT","+44203312 2125","s.markar@imperial.ac.uk",{"name":43,"role":39,"phone":44,"phoneExt":10,"email":45},"Karina Tukanova","+447751844678","karina.tukanova17@imperial.ac.uk",[47],{"facility":48,"status":49,"city":50,"state":10,"zip":51,"country":52,"countryCode":53,"cosmosGeoPoint":54,"geoPoint":59,"contacts":60},"Charing Cross Hospital","RECRUITING","London","W6 8RF","United Kingdom","UK",{"type":55,"coordinates":56},"Point",[57,58],-0.12574,51.50853,{"lat":58,"lon":57},[61],{"name":62,"role":39,"phone":44,"phoneExt":10,"email":45},"Karina Tukanova, MD",{"type":64,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100349858","oesophagectomy-and-chest-wall-and-respiratory-function-100349858",false,"NCT03835273","Oesophagectomy and Chest Wall and Respiratory Function","Changes in Respiratory Function and Chest Wall Movement Following Oesophagectomy","Inclusion Criteria:\n\n* Exposure group:\n\n  1. Patients treated more than a year ago with oesophagectomy for oesophageal cancer, by an open approach.\n  2. Patients able to understand and retain the information provided, thereby being able to give informed consent for inclusion in this study.\n* Control group:\n\n  1. Healthy volunteers with no underlying respiratory disease and no history of upper gastrointestinal surgery.\n  2. Individuals able to understand and retain the information provided, thereby being able to give informed consent for inclusion in this study.\n\nExclusion Criteria:\n\n* Any participant who lacks capacity or is unable to provide informed consent.\n* Any participant younger than 18 or older than 90 years of age.\n* Any patient with evidence of cancer recurrence or on-going postoperative complication at more than one year following surgery for oesophageal cancer.\n* Any pregnant participant.\n* unable to or excluded from performing spirometry or respiratory muscle strength testing (non-invasive testing)",true,"ALL","18 Years","90 Years",{"count":77,"type":78},100,"ESTIMATED","OBSERVATIONAL","Open surgery for esophageal cancer commonly involves large incisions in the chest, associated with a high rate of pulmonary complications (30-50%). Minimally invasive approach through keyhole surgery has been shown to reduce pulmonary infections by 20%. Enhanced recovery programmes are evidence-based protocols, developed to achieve early recovery after surgery with early mobilisation and chest physiotherapy and have been shown to reduce pulmonary complication rates as well. The investigators intend to objectively measure chest wall movement using 3D motion capture system as well as a wearable measurement system to monitor chest wall movement.",[82,83,84],"Esophageal Cancer","Esophagectomy","Respiratory Function Loss",[83,86,87,88],"Motion capture","Respiratory","Oesophageal cancer","2025-06-30",{"date":91,"type":92},"2025-07-03","ACTUAL",{"date":94,"type":92},"2019-05-29",{"date":96,"type":78},"2025-08-31",{"name":5,"class":6},1]